NO314070B1 - Hemostatisk svamp basert på kollagen, fremgangsmåte for fremstilling av denne, samt sett og sårbeskyttelse som omfatter denne - Google Patents
Hemostatisk svamp basert på kollagen, fremgangsmåte for fremstilling av denne, samt sett og sårbeskyttelse som omfatter denne Download PDFInfo
- Publication number
- NO314070B1 NO314070B1 NO19984619A NO984619A NO314070B1 NO 314070 B1 NO314070 B1 NO 314070B1 NO 19984619 A NO19984619 A NO 19984619A NO 984619 A NO984619 A NO 984619A NO 314070 B1 NO314070 B1 NO 314070B1
- Authority
- NO
- Norway
- Prior art keywords
- sponge
- collagen
- thrombin
- mixture
- weight
- Prior art date
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 53
- 108010035532 Collagen Proteins 0.000 title claims abstract description 53
- 229920001436 collagen Polymers 0.000 title claims abstract description 53
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title claims description 17
- 238000002360 preparation method Methods 0.000 title description 6
- 241000233866 Fungi Species 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 230000023555 blood coagulation Effects 0.000 claims abstract description 11
- 239000012190 activator Substances 0.000 claims abstract description 9
- 230000002760 pro-activator Effects 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 108090000190 Thrombin Proteins 0.000 claims description 48
- 229960004072 thrombin Drugs 0.000 claims description 48
- 108010049003 Fibrinogen Proteins 0.000 claims description 27
- 102000008946 Fibrinogen Human genes 0.000 claims description 27
- 229940012952 fibrinogen Drugs 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 19
- 238000004108 freeze drying Methods 0.000 claims description 15
- 239000000512 collagen gel Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000007710 freezing Methods 0.000 claims description 7
- 108010094028 Prothrombin Proteins 0.000 claims description 6
- 102100027378 Prothrombin Human genes 0.000 claims description 6
- 239000013543 active substance Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000008240 homogeneous mixture Substances 0.000 claims description 6
- 229940039716 prothrombin Drugs 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 229920005862 polyol Polymers 0.000 claims description 4
- 150000003077 polyols Chemical class 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108010074860 Factor Xa Proteins 0.000 claims description 2
- 238000004026 adhesive bonding Methods 0.000 claims description 2
- 239000000504 antifibrinolytic agent Substances 0.000 claims description 2
- 229940121375 antifungal agent Drugs 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 238000004132 cross linking Methods 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 claims description 2
- 239000002532 enzyme inhibitor Substances 0.000 claims description 2
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 238000007605 air drying Methods 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229940125532 enzyme inhibitor Drugs 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000000463 material Substances 0.000 description 22
- 206010052428 Wound Diseases 0.000 description 20
- 208000027418 Wounds and injury Diseases 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 239000010410 layer Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000000740 bleeding effect Effects 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 239000003106 tissue adhesive Substances 0.000 description 7
- 108010071289 Factor XIII Proteins 0.000 description 6
- 108010073385 Fibrin Proteins 0.000 description 6
- 102000009123 Fibrin Human genes 0.000 description 6
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940012444 factor xiii Drugs 0.000 description 6
- 229950003499 fibrin Drugs 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 108010034963 tachocomb Proteins 0.000 description 4
- 229940075469 tissue adhesives Drugs 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 2
- 101800004937 Protein C Proteins 0.000 description 2
- 102000017975 Protein C Human genes 0.000 description 2
- 101800001700 Saposin-D Proteins 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 230000001567 anti-fibrinolytic effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 239000000515 collagen sponge Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000000937 inactivator Effects 0.000 description 2
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 229960000856 protein c Drugs 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960003766 thrombin (human) Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 1
- NPUKDXXFDDZOKR-UHFFFAOYSA-N 3-(1-phenylethyl)-4-imidazolecarboxylic acid ethyl ester Chemical compound CCOC(=O)C1=CN=CN1C(C)C1=CC=CC=C1 NPUKDXXFDDZOKR-UHFFFAOYSA-N 0.000 description 1
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
- 102000004411 Antithrombin III Human genes 0.000 description 1
- 108090000935 Antithrombin III Proteins 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010048049 Factor IXa Proteins 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229940122791 Plasmin inhibitor Drugs 0.000 description 1
- 108010077971 Plasminogen Inactivators Proteins 0.000 description 1
- 102000010752 Plasminogen Inactivators Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 229940122055 Serine protease inhibitor Drugs 0.000 description 1
- 101710102218 Serine protease inhibitor Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 206010048629 Wound secretion Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 108010018823 anti-inhibitor coagulant complex Proteins 0.000 description 1
- 229940082620 antifibrinolytics Drugs 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229960005348 antithrombin iii Drugs 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940019700 blood coagulation factors Drugs 0.000 description 1
- 239000003914 blood derivative Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 108010033702 ethnor Proteins 0.000 description 1
- 229940105776 factor viii inhibitor bypassing activity Drugs 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 108010011227 meizothrombin Proteins 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000002806 plasmin inhibitor Substances 0.000 description 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000003805 procoagulant Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108010014806 prothrombinase complex Proteins 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003869 thrombin derivative Substances 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 229940033618 tisseel Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0036—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/102—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/08—Collagen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/22—Blood coagulation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Surgery (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT61196 | 1996-04-04 | ||
| PCT/EP1997/001662 WO1997037694A1 (en) | 1996-04-04 | 1997-04-02 | Hemostatic sponge based on collagen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO984619D0 NO984619D0 (no) | 1998-10-02 |
| NO984619L NO984619L (no) | 1998-12-03 |
| NO314070B1 true NO314070B1 (no) | 2003-01-27 |
Family
ID=3495187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19984619A NO314070B1 (no) | 1996-04-04 | 1998-10-02 | Hemostatisk svamp basert på kollagen, fremgangsmåte for fremstilling av denne, samt sett og sårbeskyttelse som omfatter denne |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6649162B1 (ru) |
| EP (1) | EP0891193B1 (ru) |
| JP (2) | JP2000510357A (ru) |
| AT (1) | ATE247494T1 (ru) |
| AU (1) | AU726163B2 (ru) |
| CA (1) | CA2251475C (ru) |
| CZ (1) | CZ318998A3 (ru) |
| DE (1) | DE69724243T2 (ru) |
| HU (1) | HUP9903586A3 (ru) |
| NO (1) | NO314070B1 (ru) |
| RU (1) | RU2193897C2 (ru) |
| SK (1) | SK284693B6 (ru) |
| WO (1) | WO1997037694A1 (ru) |
Families Citing this family (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7435425B2 (en) | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
| US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US8603511B2 (en) | 1996-08-27 | 2013-12-10 | Baxter International, Inc. | Fragmented polymeric compositions and methods for their use |
| US8303981B2 (en) | 1996-08-27 | 2012-11-06 | Baxter International Inc. | Fragmented polymeric compositions and methods for their use |
| DE10025001A1 (de) * | 2000-05-22 | 2001-11-29 | Aventis Behring Gmbh | Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften |
| ATE346145T1 (de) * | 1999-09-27 | 2006-12-15 | Sysmex Corp | Verfahren zur stabilisierung von thrombin |
| DE60018480T2 (de) * | 2000-03-09 | 2006-02-16 | Syntacoll Ag | Mehrschicht-kollagenmatrix zur geweberekonstruktion |
| AT411326B (de) * | 2000-06-20 | 2003-12-29 | Biering Wolfgang | Hämostatische collagen-pellets |
| US6890342B2 (en) * | 2000-08-02 | 2005-05-10 | Loma Linda University | Method and apparatus for closing vascular puncture using hemostatic material |
| ATE286408T1 (de) * | 2000-10-23 | 2005-01-15 | Tissuemed Ltd | Selbstklebende, hydratierbare matrix für therapeutische anwendungen |
| BRPI0206705B8 (pt) * | 2001-01-25 | 2021-07-27 | Nycomed Pharma As | método para preparar uma esponja de colágeno. |
| US7098315B2 (en) | 2001-01-25 | 2006-08-29 | Nycomed Pharma As | Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| US6733774B2 (en) | 2001-01-25 | 2004-05-11 | Nycomed Pharma As | Carrier with solid fibrinogen and solid thrombin |
| US7052713B2 (en) | 2001-02-13 | 2006-05-30 | Nycomed Pharma As | Carrier with solid fibrinogen and solid thrombin |
| US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| AU2003232257A1 (en) * | 2002-05-08 | 2003-11-11 | Rheinisch-Westfalische Technische Hochschule Aachen (Rwth) | Resorbable pharmaceutical formulation for the continuous release of thrombin |
| CN1306910C (zh) | 2002-06-14 | 2007-03-28 | 洛马林达大学医学中心 | 封闭血管伤口的装置 |
| US20040106344A1 (en) * | 2002-06-28 | 2004-06-03 | Looney Dwayne Lee | Hemostatic wound dressings containing proteinaceous polymers |
| AU2003302906B2 (en) | 2002-12-11 | 2009-04-02 | Ferrosan Medical Devices A/S | Gelatine-based materials as swabs |
| US20040122349A1 (en) | 2002-12-20 | 2004-06-24 | Lafontaine Daniel M. | Closure device with textured surface |
| US8709038B2 (en) | 2002-12-20 | 2014-04-29 | Boston Scientific Scimed, Inc. | Puncture hole sealing device |
| WO2004064878A1 (ja) * | 2003-01-20 | 2004-08-05 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | 止血用材料 |
| KR20060003872A (ko) * | 2003-04-04 | 2006-01-11 | 티슈메드 리미티드 | 조직-부착성 제형물 |
| US8834864B2 (en) | 2003-06-05 | 2014-09-16 | Baxter International Inc. | Methods for repairing and regenerating human dura mater |
| US7942897B2 (en) | 2003-07-10 | 2011-05-17 | Boston Scientific Scimed, Inc. | System for closing an opening in a body cavity |
| US7927626B2 (en) | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
| JP4722044B2 (ja) | 2003-08-14 | 2011-07-13 | ローマ リンダ ユニヴァーシティ メディカル センター | 血管創傷閉鎖機器 |
| US8187627B2 (en) * | 2003-09-05 | 2012-05-29 | Loma Linda University Medical Center | Dressing delivery system for internal wounds |
| RU2377022C9 (ru) | 2004-01-30 | 2010-08-10 | Ферросан А/С | Гемостатические спреи и композиции |
| CA2567297A1 (en) * | 2004-05-21 | 2005-12-01 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Tissue sealant |
| JP4959557B2 (ja) | 2004-07-09 | 2012-06-27 | フェロサン メディカル デバイシーズ エイ／エス | ヒアルロン酸含有止血合成剤 |
| BRPI0514106A (pt) * | 2004-08-03 | 2008-05-27 | Tissuemed Ltd | materiais adesivos a tecidos |
| US20060258995A1 (en) * | 2004-10-20 | 2006-11-16 | Pendharkar Sanyog M | Method for making a reinforced absorbable multilayered fabric for use in medical devices |
| CA2584698C (en) * | 2004-10-20 | 2014-02-25 | Ethicon, Inc. | A reinforced absorbable multilayered hemostatic wound dressing and method of making |
| US9358318B2 (en) * | 2004-10-20 | 2016-06-07 | Ethicon, Inc. | Method of making a reinforced absorbable multilayered hemostatic wound dressing |
| US20060257457A1 (en) * | 2004-10-20 | 2006-11-16 | Gorman Anne J | Method for making a reinforced absorbable multilayered hemostatic wound dressing |
| CA2626683C (en) * | 2004-10-20 | 2013-07-02 | Ethicon, Inc. | A reinforced absorbable multilayered fabric for use in tissue repair and regeneration |
| EP1833517B1 (en) * | 2004-12-14 | 2008-09-24 | Fidia Advanced Biopolymers S.R.L. | Process for the preparation of two and three dimensional polymer scaffolds |
| US20060142798A1 (en) * | 2004-12-27 | 2006-06-29 | Holman Thomas J | Device and method for closing an opening in a body cavity or lumen |
| DK1879606T3 (da) | 2005-04-25 | 2013-09-23 | Massachusetts Inst Technology | Selvorganiserende peptider til fremme af hæmostase |
| JP2006306759A (ja) * | 2005-04-27 | 2006-11-09 | Fujimori Kogyo Co Ltd | トロンビン医薬製剤 |
| US7429241B2 (en) | 2005-09-29 | 2008-09-30 | Codman & Shurtleff, Inc. | Dural graft and method of preparing the same |
| US8088145B2 (en) | 2005-10-05 | 2012-01-03 | Loma Linda University Medical Center | Vascular wound closure device and method |
| WO2007088402A2 (en) | 2006-02-03 | 2007-08-09 | Tissuemed Limited | Tissue-adhesive materials |
| US20090018575A1 (en) * | 2006-03-01 | 2009-01-15 | Tissuemed Limited | Tissue-adhesive formulations |
| AU2007230945B2 (en) | 2006-03-23 | 2013-05-02 | The Penn State Research Foundation | Heart assist device with expandable impeller pump |
| EP2012842B1 (en) | 2006-04-25 | 2018-04-04 | Massachusetts Institute of Technology | Compositions and methods for affecting movement of contaminants, bodily fluids or other entities and/or affecting other physiological conditions |
| EP2021045B1 (en) | 2006-05-31 | 2016-03-16 | Baxter International Inc. | Collagen for use in prevention of peridural fibrosis formation after spinal surgery |
| TWI436793B (zh) | 2006-08-02 | 2014-05-11 | Baxter Int | 快速作用之乾密封膠及其使用和製造方法 |
| CN101516302B (zh) * | 2006-08-04 | 2013-08-21 | Stb有限公司 | 固体创伤敷料的生产方法 |
| WO2008076407A2 (en) | 2006-12-15 | 2008-06-26 | Lifebond Ltd. | Gelatin-transglutaminase hemostatic dressings and sealants |
| DE102007037051A1 (de) * | 2007-07-24 | 2009-01-29 | Aesculap Ag | Flächiges Implantat |
| AU2008317874B2 (en) | 2007-10-30 | 2013-12-19 | Baxter Healthcare S.A. | Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects |
| US8642831B2 (en) | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
| CA2721335A1 (en) | 2008-04-16 | 2009-10-22 | Ryoichi Kawamura | Process for preparing bioabsorbable sheet preparation holding thrombin |
| AU2009261559B2 (en) | 2008-06-18 | 2014-01-16 | Lifebond Ltd | Improved cross-linked compositions |
| EP3470093B1 (en) | 2008-10-06 | 2020-08-19 | 3-D Matrix Ltd. | Tissue plug |
| US8613943B2 (en) * | 2009-01-23 | 2013-12-24 | Royal College Of Surgeons In Ireland | Process for producing a multi-layered scaffold suitable for osteochondral repair |
| US9039783B2 (en) | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
| KR101873254B1 (ko) * | 2009-06-11 | 2018-07-02 | 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 창상 피복재 |
| EP2442835B1 (en) | 2009-06-16 | 2014-12-10 | Baxter International Inc | Hemostatic sponge |
| EP2477617B1 (en) | 2009-09-18 | 2018-01-31 | Bioinspire Technologies Inc. | Free-standing biodegradable patch |
| US9271925B2 (en) | 2013-03-11 | 2016-03-01 | Bioinspire Technologies, Inc. | Multi-layer biodegradable device having adjustable drug release profile |
| DE102009053305A1 (de) | 2009-11-12 | 2011-08-18 | medichema GmbH, 09112 | Verfahren zur Herstellung einer schichtförmigen Wundauflage |
| US9439941B2 (en) | 2009-12-14 | 2016-09-13 | The University Of Hong Kong | Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells |
| MX2012007056A (es) * | 2009-12-16 | 2012-09-28 | Baxter Healthcare Sa | Esponja hemostatica. |
| ES2551388T3 (es) | 2009-12-22 | 2015-11-18 | Lifebond Ltd | Modificación de agentes de entrecruzamiento enzimáticos para controlar las propiedades de las matrices entrecruzadas |
| CA2790248A1 (en) * | 2010-03-15 | 2011-09-22 | Ferrosan Medical Devices A/S | A method for promotion of hemostasis and/or wound healing |
| SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
| JP6289096B2 (ja) | 2010-06-01 | 2018-03-07 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | 乾燥した安定な止血組成物を作製するためのプロセス |
| KR101814841B1 (ko) | 2010-06-01 | 2018-01-03 | 백스터 인터내셔널 인코포레이티드 | 건조 및 안정한 지혈 조성물의 제조 방법 |
| EP2575770B1 (en) | 2010-06-01 | 2017-03-22 | Baxter International Inc | Process for making dry and stable hemostatic compositions |
| CN103096944A (zh) * | 2010-07-20 | 2013-05-08 | 一般财团法人化学及血清疗法研究所 | 组织粘合用片制剂 |
| AU2011287215B2 (en) * | 2010-08-05 | 2015-09-10 | Lifebond Ltd. | Dry composition wound dressings and adhesives |
| DE102010038155A1 (de) | 2010-10-05 | 2012-04-05 | Technische Universität Ilmenau | Einem biologischen Gewebe nachgebildete Struktur und Verfahren zu deren Herstellung |
| CN102357259A (zh) * | 2011-07-28 | 2012-02-22 | 王珊珊 | 一种生物蛋白海绵及其制备方法 |
| WO2013048787A1 (en) * | 2011-09-26 | 2013-04-04 | Yes, Inc. | Novel hemostatic compositions and dressings for bleeding |
| MX346958B (es) | 2011-10-11 | 2017-04-06 | Baxter Int | Composición hemostatica. |
| KR102102002B1 (ko) | 2011-10-11 | 2020-04-20 | 백스터 인터내셔널 인코포레이티드 | 지혈 조성물 |
| WO2013060770A1 (en) | 2011-10-27 | 2013-05-02 | Baxter International Inc. | Hemostatic compositions |
| CN104159527B (zh) | 2012-03-06 | 2017-04-12 | 弗罗桑医疗设备公司 | 包含止血糊剂的压力容器 |
| CN104349797B (zh) | 2012-06-12 | 2017-10-27 | 弗罗桑医疗设备公司 | 干止血组合物 |
| CN104902974B (zh) | 2012-07-06 | 2017-07-28 | 三维矩阵有限公司 | 肽溶液的灌装加工法 |
| CA2912357C (en) | 2013-06-21 | 2019-12-31 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
| IL229645A0 (en) * | 2013-11-26 | 2014-03-31 | Omrix Biopharmaceuticals Ltd | A dry bandage containing thrombin and pectin |
| JP6489485B2 (ja) | 2013-12-11 | 2019-03-27 | フェロサン メディカル デバイシーズ エイ／エス | 押し出し増強因子を含んでいる乾燥組成物 |
| CN106456811B (zh) | 2014-03-10 | 2021-04-02 | 三维矩阵有限责任公司 | 肽组合物的灭菌和过滤 |
| DK3116896T3 (en) | 2014-03-10 | 2019-03-18 | 3 D Matrix Ltd | SELF-PREPARING PEPTIME COMPOSITIONS |
| WO2015138478A1 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Autoassembling peptides for the treatment of pulmonary bulla |
| DE102014106711A1 (de) | 2014-05-13 | 2015-11-19 | Bayer Innovation Gmbh | Verwendung von siliziumhaltigen Fasern und/oder einer Fasermatrix als bioresorbierbares Wundvlies |
| KR101536134B1 (ko) * | 2014-09-26 | 2015-07-14 | 세원셀론텍(주) | 연부조직 수복용 매트릭스의 제조방법 |
| CN106999621B (zh) | 2014-10-13 | 2020-07-03 | 弗罗桑医疗设备公司 | 用于止血和伤口愈合的干组合物 |
| BR112017013565B1 (pt) | 2014-12-24 | 2021-12-28 | Ferrosan Medical Devices A/S | Seringa para retenção e mistura de primeira e segunda substâncias |
| KR101664415B1 (ko) * | 2015-01-12 | 2016-10-12 | 주식회사 한국비엔씨 | 약물을 포함하는 콜라겐 창상피복재 및 이의 제조방법 |
| CA2976672A1 (en) | 2015-02-10 | 2016-08-18 | Lifenet Health | Biologically functional soft tissue scaffolds and implants |
| KR20170125061A (ko) * | 2015-02-27 | 2017-11-13 | 폴리가닉스 아이피 비.브이. | 약물 용출 발포체 및 그 제조 |
| CN107771093B (zh) | 2015-07-03 | 2021-06-15 | 弗罗桑医疗设备公司 | 用于混合两种组分和用于在存储条件下保持真空的注射器 |
| US10814038B2 (en) | 2016-01-06 | 2020-10-27 | 3-D Matrix, Ltd. | Combination compositions |
| CN110382011A (zh) | 2017-03-09 | 2019-10-25 | 巴克斯特国际公司 | 溶剂沉积系统和方法 |
| RU176884U1 (ru) * | 2017-09-25 | 2018-01-31 | Павел Борисович Панов | Кровоостанавливающий пакет |
| US11324703B2 (en) | 2017-12-15 | 2022-05-10 | 3-D Matrix, Ltd. | Surfactant peptide nanostructures and uses thereof in drug delivery |
| JP7395113B2 (ja) | 2018-05-09 | 2023-12-11 | フェロサン メディカル デバイシーズ エイ／エス | 止血組成物を調製する方法 |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
| RU2701195C1 (ru) * | 2018-11-28 | 2019-09-25 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) | Способ получения искусственных губок в микропробирках для проведения лабораторных исследований in vitro |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1717118A1 (de) * | 1964-05-16 | 1972-10-19 | Spofa Vereinigte Pharma Werke | Verfahren zur Herstellung von Kollagenschaum |
| US3514518A (en) * | 1967-12-19 | 1970-05-26 | Pierre Charier Vadrot | Process for preparation of gelatinous material from animal collagen |
| US3823212A (en) * | 1968-11-27 | 1974-07-09 | Freudenberg C Fa | Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers |
| US4390519A (en) * | 1978-05-19 | 1983-06-28 | Sawyer Philip Nicholas | Bandage with hemostatic agent and methods for preparing and employing the same |
| US4404970A (en) * | 1978-05-19 | 1983-09-20 | Sawyer Philip Nicholas | Hemostatic article and methods for preparing and employing the same |
| US4279812A (en) * | 1979-09-12 | 1981-07-21 | Seton Company | Process for preparing macromolecular biologically active collagen |
| DE3019612A1 (de) * | 1980-05-22 | 1981-11-26 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabilisiertes thrombinpraeparat |
| CA1156529A (en) * | 1980-06-12 | 1983-11-08 | Fred A. Serravallo | Fibrous collagenous hemostatic-adhesive webs |
| US4292972A (en) * | 1980-07-09 | 1981-10-06 | E. R. Squibb & Sons, Inc. | Lyophilized hydrocolloio foam |
| DE3037513C2 (de) * | 1980-10-03 | 1983-05-05 | Steffan, Wolfgang, 8425 Neustadt | Kollagene Wundauflage |
| DE3105624A1 (de) * | 1981-02-16 | 1982-09-02 | Hormon-Chemie München GmbH, 8000 München | Material zum abdichten und heilen von wunden |
| DE3212412C2 (de) * | 1982-04-02 | 1986-01-02 | Dr. Ruhland Nachf. GmbH, 8425 Neustadt | Gewebeverklebbare kollagene Wundauflage |
| US4515637A (en) * | 1983-11-16 | 1985-05-07 | Seton Company | Collagen-thrombin compositions |
| US4600574A (en) * | 1984-03-21 | 1986-07-15 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Method of producing a tissue adhesive |
| US4925924A (en) * | 1984-03-27 | 1990-05-15 | University Of Medicine And Dentistry Of New Jersey | Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof |
| US4606910A (en) * | 1984-06-28 | 1986-08-19 | Interface Biomedical Laboratories | Composite hemostatic article including a hemostatic agent onlay and methods for preparing the same |
| DE3533423A1 (de) | 1985-09-19 | 1987-03-26 | Wolf Gmbh Richard | Applikator-zangeneinsatz fuer chirurgische handhabe zur anwendung in der endoskopie |
| US4696812A (en) * | 1985-10-28 | 1987-09-29 | Warner-Lambert Company | Thrombin preparations |
| ZA88227B (en) * | 1987-01-28 | 1988-06-30 | Warner-Lambert Company | Thrombin preparations |
| JPS6440433A (en) * | 1987-08-05 | 1989-02-10 | Green Cross Corp | Aqueous liquid composition of thrombin |
| US4891359A (en) | 1988-12-08 | 1990-01-02 | Johnson & Johnson Patient Care, Inc. | Hemostatic collagen paste composition |
| DK223389D0 (da) * | 1989-05-05 | 1989-05-05 | Ferrosan As | Saarsvamp |
| JPH039747U (ru) * | 1989-06-20 | 1991-01-30 | ||
| FR2679778B1 (fr) * | 1991-08-02 | 1995-07-07 | Coletica | Utilisation de collagene reticule par un agent de reticulation pour la fabrication d'une membrane suturable, biocompatible, a resorption lente, ainsi qu'une telle membrane. |
| US5331092A (en) * | 1992-11-06 | 1994-07-19 | Coletica | Process of preparation of collagen containing in major proportion insoluble collagen and collagen having high mechanical resistance and thermal stability obtained thereby |
| JP3172289B2 (ja) | 1992-11-18 | 2001-06-04 | 三洋電機株式会社 | 熱交換ユニット |
| US5836970A (en) * | 1996-08-02 | 1998-11-17 | The Kendall Company | Hemostatic wound dressing |
-
1997
- 1997-04-02 RU RU98119893/14A patent/RU2193897C2/ru not_active IP Right Cessation
- 1997-04-02 AT AT97918102T patent/ATE247494T1/de not_active IP Right Cessation
- 1997-04-02 SK SK1373-98A patent/SK284693B6/sk not_active IP Right Cessation
- 1997-04-02 WO PCT/EP1997/001662 patent/WO1997037694A1/en not_active Application Discontinuation
- 1997-04-02 AU AU26359/97A patent/AU726163B2/en not_active Expired
- 1997-04-02 DE DE69724243T patent/DE69724243T2/de not_active Expired - Lifetime
- 1997-04-02 CZ CZ983189A patent/CZ318998A3/cs unknown
- 1997-04-02 US US09/155,569 patent/US6649162B1/en not_active Expired - Lifetime
- 1997-04-02 JP JP09535819A patent/JP2000510357A/ja not_active Withdrawn
- 1997-04-02 HU HU9903586A patent/HUP9903586A3/hu unknown
- 1997-04-02 EP EP97918102A patent/EP0891193B1/en not_active Expired - Lifetime
- 1997-04-02 CA CA002251475A patent/CA2251475C/en not_active Expired - Lifetime
-
1998
- 1998-10-02 NO NO19984619A patent/NO314070B1/no not_active IP Right Cessation
-
2009
- 2009-10-29 JP JP2009248693A patent/JP5373553B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| RU2193897C2 (ru) | 2002-12-10 |
| EP0891193A1 (en) | 1999-01-20 |
| SK137398A3 (en) | 1999-03-12 |
| DE69724243T2 (de) | 2004-06-17 |
| CA2251475C (en) | 2006-09-05 |
| JP2010046516A (ja) | 2010-03-04 |
| AU726163B2 (en) | 2000-11-02 |
| SK284693B6 (sk) | 2005-09-08 |
| ATE247494T1 (de) | 2003-09-15 |
| HUP9903586A2 (hu) | 2000-03-28 |
| DE69724243D1 (de) | 2003-09-25 |
| JP2000510357A (ja) | 2000-08-15 |
| WO1997037694A1 (en) | 1997-10-16 |
| HUP9903586A3 (en) | 2003-02-28 |
| US6649162B1 (en) | 2003-11-18 |
| JP5373553B2 (ja) | 2013-12-18 |
| NO984619L (no) | 1998-12-03 |
| EP0891193B1 (en) | 2003-08-20 |
| CZ318998A3 (cs) | 1999-09-15 |
| AU2635997A (en) | 1997-10-29 |
| NO984619D0 (no) | 1998-10-02 |
| CA2251475A1 (en) | 1997-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU726163B2 (en) | Hemostatic sponge based on collagen | |
| JP3602441B2 (ja) | フィブリンスポンジ | |
| TWI511753B (zh) | 止血棉 | |
| KR101811070B1 (ko) | 지혈 스폰지 | |
| JP5719355B2 (ja) | 止血スポンジ | |
| CN105828844B (zh) | 包含挤出增强剂的干组合物 | |
| EP3496769B1 (en) | Hemostatic compositions and methods of making thereof | |
| EP3752212B1 (en) | Method of making hemostatic compositions | |
| CN101854960A (zh) | 明胶-转谷氨酰胺酶止血敷料和密封材料 | |
| EP3074055B1 (en) | Dry pad comprising thrombin and pectin | |
| JP2020509802A (ja) | 溶媒デポジションシステム及び方法 | |
| JPH0199565A (ja) | フィブリン糊調製用キット | |
| US20220111020A1 (en) | Hemostatic compositions and methods of making thereof | |
| MXPA00002673A (en) | Fibrin sponge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |